Gnauck R
Z Gastroenterol. 1982 Feb;20(2):84-92.
Haemoccult was compared once more with hemoFEC after improvements of the latter material in 1979. 3200 patients were tested parallel with both materials. Haemoccult was positive in 149 patients = 4.6%, hemoFEC was positive in 129 patients = 4.0%. With Haemoccult 22 cancers and 26 large polyps were traced, with hemoFEC 20 cancers and 25 adenomas. 2 cancers and 19 large polyps were negative with both tests. Since 1972 a total of 25.700 patients have been tested with Haemoccult as part of the routine check-program, 873 = 3.4% had a positive test. Of the 600 examined, 124 had colorectal cancer and 196 had a large polyp. By reviewing the charts of all cancers and polyps diagnosed, 19 out of 143 cancers = 13% and 136 out of 332 polyps = 41% had a false-negative Haemoccult test on one-time, initial testing.
1979年对血隐(Haemoccult)与粪隐血免疫检测法(hemoFEC)进行了再次比较,后者在此之前已得到改进。3200名患者同时接受了这两种检测。血隐检测呈阳性的有149例患者,占4.6%;粪隐血免疫检测法呈阳性的有129例患者,占4.0%。血隐检测发现了22例癌症和26个大息肉,粪隐血免疫检测法发现了20例癌症和25个腺瘤。两种检测均呈阴性的有2例癌症和19个大息肉。自1972年以来,共有25700名患者接受了血隐检测,作为常规检查项目的一部分,检测呈阳性的有873例,占3.4%。在接受检查的600例患者中,124例患有结直肠癌,196例有大息肉。通过查阅所有确诊癌症和息肉的病历,在143例癌症中有19例(占13%)、在332例息肉中有136例(占41%)在首次一次性检测时血隐检测呈假阴性。